Journal of Anesthesia

, Volume 5, Issue 1, pp 24–29 | Cite as

Changes in the plasma histamine concentration after the administration of vecuronium bromide

  • Hiromasa Mitsuhata
  • Shigeru Matsumoto
  • Keiji Enzan
  • Masaya Yabe
  • Hiromichi Terada
Original Articles

Abstract

Clinical symptoms of anaphylactoid reaction to muscle relaxants vary from localized flush to cardiovascular collapse. Vecuronium bromide is reported to have very little histamine releasing property. However, there are some reports of anaphylaxis or anaphylactoid reaction to vecuronium. We studied plasma histamine concentration after the intravenous injection of vecuronium to confirm the histamine release. Twenty patients were randomly allocated to one of two groups, each group comprising of 10 patients: one group was to receive vecuronium 0.1 mg·kg−1 and the other 0.2 mg·kg−1 using the priming principle. Blood samples were taken prior to and 1, 3, 5, 8 and 13 min after the administration of vecuronium. The plasma histamine concentration was measured by radioimmunoassay with monoclonal antibody. There were no significant changes in plasma histamine concentration over 13 min after the administration of vecuronium compared with the baseline value. There were also no significant differences between these two groups. We concluded that vecuronium up to 0.2 mg·kg−1 did not change the plasma histamine concentration in the patients having no previous history of allergy or atopic tendencies.

Key words

vecuronium histamine priming principle radioimmunoassay 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fisher MM, Munro I: Life-threatening anaphylactoid reactions to muscle relaxants. Anesth Analg 62:559–564, 1983CrossRefPubMedGoogle Scholar
  2. 2.
    Galletly DC: Comparative cutaneous histamine release by neuromuscular blocking agents. Anaesth Intens Care 14:365–369, 1986Google Scholar
  3. 3.
    Booiji LHDJ, Krieg N, Crul JF: Intradermal histamine releasing effect caused by Org-NC 45. Acta Anaesthesiol Scand 24:393–394, 1980CrossRefGoogle Scholar
  4. 4.
    Robertson EN, Booij HDJ, Fragen RJ, Crul JF: Intradermal histamine release by 3 muscle relaxants. Acta Anaesthesiol Scand 27:203–205, 1983CrossRefPubMedGoogle Scholar
  5. 5.
    Lavery GG, Hewitt AJ, Kenny NT: Possible histamine release after vecuronium. Anaesthesia 40:389–390, 1985PubMedGoogle Scholar
  6. 6.
    Clayton DG, Watkins J: Histamine release with vecuronium. Anesthesia 39:1143–1144, 1984CrossRefGoogle Scholar
  7. 7.
    Durrani Z, O’Hara J: Histaminoid reaction from vecuronium priming: A case report. Anesthesiology 67:130–132. 1987CrossRefPubMedGoogle Scholar
  8. 8.
    O’Callaghan AC, Scadding G, Watkins J: Bronchospasm following the use of vecuronium. Anaesthesia 41:940–942, 1986CrossRefPubMedGoogle Scholar
  9. 9.
    McBride P, Bradley D, Kaliner M: Evaluation of radioimmunoassay for histamine measurement in biologic fluids. J Allergy Clin Immunol 82:638–646, 1988CrossRefPubMedGoogle Scholar
  10. 10.
    Schwarz S, Ilias W, Lacker F, Maryhofer O, Foldes FF: Rapid tracheal intubation with vecuronium: The priming principle. Anesthesiology 62:388–391, 1985CrossRefPubMedGoogle Scholar
  11. 11.
    Watkins J: Tests in vivo and in vitro of hypersensitivity response, Guide to immediate anaesthetic reactions. Edited by Watkins, J, Levy, CJ. London, Butterworths, 1988, pp. 101–115Google Scholar
  12. 12.
    McBride P, Bradley D, Kaliner M: Evaluation of a radioimmunoassay for histamine measurement in biologic fluids. J. Allergy Clin Immunol 82:638–646, 1988CrossRefPubMedGoogle Scholar
  13. 13.
    Holgate ST, Robinson C, Church MK: Mediators of immediate hypersensitivity, Allergy: Principles and practice. Edited by Middleton, E, Reed, CE, Ellis, EF, Adkinson, NF, Yunginger, JW. ST. Louis, C.V. Mosby, 1988, pp. 135–163Google Scholar
  14. 14.
    Basta SJ, Savarreses JJ, Ali HH, Sunder N, Moss J, Gionfriddo M, Embree P: Vecuronium does not alter serum histamine within the clinical dose range. Anesthesiology 59:A273, 1983CrossRefGoogle Scholar
  15. 15.
    Goudsouzian NG, Young ET, Moss J, Liu LMP: Histamine release during the administration of atracurium or vecuronium in children. Br J Anaesth 58:1229–1233, 1986CrossRefPubMedGoogle Scholar
  16. 16.
    Cannon JE, Fahey MR: Large doses of vecuronium and plasma histamine concentration. Can J Anaesth 35:350–363, 1988CrossRefPubMedGoogle Scholar
  17. 17.
    North FC, Kettelkamp N, Hirshman CA: Comparision of cutaneous and in vitro histamine release by muscle relaxants. Anesthesiology 66:543–546, 1987CrossRefPubMedGoogle Scholar
  18. 18.
    Kaliner M, Shelhamer JH, Ottesen EA: Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 69:283–289, 1982CrossRefPubMedGoogle Scholar
  19. 19.
    Kettlekamp NS, Austin DR, Downes H, Cheek DBC, Hirshman CA: Inhibition of d-tubocurarine-induced histamine release by halothane. Anesthesiology 66:666–669, 1987CrossRefPubMedGoogle Scholar
  20. 20.
    Moneret-Vautrin DA, Laxenaire MC, Mouton C: Anapylaxie croisée avec le vécuronium. Ann Fr Anésth Reanim 3:467, 1984PubMedGoogle Scholar
  21. 21.
    Harle DG, Baldo BA, Fisher MM: Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Br J Anaesth 57:1073–1076, 1985CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Society of Anesthesiologists 1991

Authors and Affiliations

  • Hiromasa Mitsuhata
    • 1
  • Shigeru Matsumoto
    • 1
  • Keiji Enzan
    • 2
  • Masaya Yabe
    • 1
  • Hiromichi Terada
    • 1
  1. 1.Department of AnesthesiologyHiraka General HospitalAkitaJapan
  2. 2.Department of AnesthesiologyAkita University School of MedicineAkitaJapan

Personalised recommendations